Placental abruptionMANAGEMENT

OBSTETRIC PRESENTATIONS · 12 SECTIONS

⚲

395 items

☷ Legend

⚲

Cardiovascular Presentations66▾

Respiratory Presentations47▾

Neurological Presentations77▾

Gastrointestinal Presentations63▾

Genitourinary and Reproductive Presentations44▾

Infectious Disease Presentations146▾

Trauma Presentations88▾

Toxicologic Presentations67▾

Psychiatric Presentations25▾

Musculoskeletal and Rheumatologic Presentations89▾

Dermatology Presentations21▾

Environmental and Exposure Presentations26▾

Hematologic and Oncologic Presentations30▾

Pediatric-Specific Presentations13▾

Endocrine and Metabolic Presentations42▾

ENT and Maxillofacial Presentations21▾

Ophthalmologic Presentations15▾

Obstetric Presentations17▾

Eclampsia Ectopic Pregnancy (Ruptured)Ectopic Pregnancy (Unruptured)HELLP Syndrome Hyperemesis gravidarum Placenta previa Placental abruption Postpartum Endometritis Postpartum hemorrhage Postpartum infection Preeclampsia Preeclampsia:eclampsia Preterm labor Spontaneous Abortion (Incomplete)Spontaneous Abortion (Missed)Spontaneous Abortion (Threatened)Threatened:inevitable:incomplete abortion

Systemic and Miscellaneous Presentations15▾

01Approach to the Critical Patient/attcp39

Immediate priorities

›High risk obstetric hemorrhage approach

›Resuscitation bay triggers

›Systolic blood pressure <90 mmHg

›Heart rate >120 beats/min

›Altered mental status

›Ongoing heavy vaginal bleeding

›Airway and breathing

›If respiratory distress or shock, airway support and oxygenation

›If intubation, left uterine displacement

›Circulation

›Two large bore IV lines

›Rapid transfuser readiness

›If shock, activate massive transfusion protocol

›Monitoring

›Continuous ECG

›Continuous pulse oximetry

›Noninvasive blood pressure every 3 to 5 minutes

›If unstable, arterial line for titration and frequent sampling

Hemorrhage and fetal safety

›Maternal first framework

›Maternal stabilization as priority for fetal survival

›Left uterine displacement to reduce aortocaval compression

›Normothermia and active warming

›Calcium monitoring during transfusion

›Fetal assessment integration

›Continuous external fetal monitoring if viable gestational age and resources available

›Category III fetal heart tracing as urgent obstetric escalation trigger

›Bedside ultrasound for fetal cardiac activity if uncertainty

Consults and time critical decisions

›Team activation

›Obstetrics immediate involvement

›Anesthesia early involvement for possible operative delivery

›Neonatology if preterm viable fetus

›Blood bank notification for anticipated high product use

›Delivery decision points

›If maternal instability, immediate delivery pathway based on obstetric assessment

›If fetal distress with viable fetus, expedited delivery pathway

›If fetal demise, maternal stabilization and hemorrhage control focus

›Transfer considerations

›If no operative obstetric capability, immediate transfer planning with ongoing resuscitation

›If unstable, transfer only if safer than local temporizing delivery options

02History/hx57

Core presentation

›Symptom pattern

›Vaginal bleeding

›Concealed abruption possibility with minimal external bleeding

›Sudden onset bleeding

›Abdominal pain

›Constant pain

›Back pain

›Uterine activity

›Frequent contractions

›Hypertonic uterus sensation

›Decreased fetal movements

›Recent change from baseline

›Time since last perceived movement

›Timeline

›Gestational age estimate

›Symptom onset time

›Bleeding quantity progression

›Pain progression

Risk factors

›Maternal and pregnancy risks

›Hypertensive disorders of pregnancy

›Preeclampsia or gestational hypertension

›Chronic hypertension

›Trauma

›Motor vehicle collision

›Fall

›Intimate partner violence

›Prior abruption

›Previous pregnancy history

›Substance exposure

›Cocaine or stimulant use

›Tobacco use

›Uterine factors

›Uterine overdistension

›Multiple gestation

›Polyhydramnios

›Membrane and cord factors

›Premature rupture of membranes

›Short umbilical cord concern

›Medication and bleeding risks

›Anticoagulant use

›Known bleeding disorder

Obstetric context and comorbidities

›Pregnancy history

›Gravidity and parity

›Prior cesarean delivery

›Prior placenta previa history

›Current pregnancy complications

›Fetal growth restriction

›Known placental abnormalities

›Baseline health

›Cardiovascular disease

›Renal disease

›Diabetes mellitus

PITFALLS

›Common misses

›Reassurance from low visible bleeding

›Reassurance from a normal ultrasound

›Anchoring on placenta previa without considering abruption

›Delayed blood product activation in apparent stable patients

03Physical Exam/exam34

Maternal hemodynamics and perfusion

›Vital signs and shock markers

›Hypotension

›Narrow pulse pressure

›Orthostatic changes

›Tachycardia

›Tachypnea

›Fever alternative diagnosis consideration

›Shock index elevation

›Perfusion exam

›Capillary refill delay

›Cool clammy extremities

›Altered mental status

›Oliguria or anuria

Abdominal and uterine findings

›Uterine tone and tenderness

›Firm board like uterus

›Uterine tenderness

›Persistent contractions

›Abdominal exam

›Guarding or peritonism

›Fundal height discrepancy

›Vaginal bleeding assessment

›External bleeding quantity

›Clots

›Cervical dilation status if assessed by obstetrics

Fetal assessment

›Bedside fetal status

›Fetal heart rate presence

›Fetal heart rate pattern if monitoring in place

›Contraction pattern

›Frequent contractions

›Uterine tachysystole

PITFALLS

›Exam limitations

›Normal appearing cervix does not exclude abruption

›Soft uterus early does not exclude evolving abruption

›Pain out of proportion as a severe sign even with scant bleeding

04Differential Diagnosis/ddx20

Obstetric life threats

›Bleeding in pregnancy differential

›Placenta previa ICD-10 O44

›Vasa previa

›Uterine rupture ICD-10 O71.1

›Cervical insufficiency with bleeding

›Preterm labor with bloody show

›Hypertensive and placental disorders

›Severe preeclampsia with hepatic involvement

›HELLP syndrome ICD-10 O14.2

›Infection and inflammation

›Chorioamnionitis

Non obstetric mimics and contributors

›Abdominal pain mimics

›Appendicitis

›Ovarian torsion

›Nephrolithiasis

›Hemorrhage sources

›Cervical or vaginal laceration

›Uterine atony postpartum context

›Trauma related

›Solid organ injury with hemoperitoneum

05Laboratory Tests/lt37

Hemorrhage and anemia

›Hemoglobin and platelets overview

›Complete blood count for bleeding concern

›Hemoglobin trend for occult loss

›Platelet count for consumption and transfusion planning

›Type and screen

›Antibody screen status

›Crossmatch volume planning

›Metabolic and perfusion markers

›Venous blood gas or arterial blood gas if shock

›pH and bicarbonate for severity

›PaCO2 and PaO2 in mmHg if arterial sample

›Lactate in mmol/l

›Trend for resuscitation response

›Persistent elevation as ongoing hypoperfusion marker

Coagulopathy and DIC risk

›Coagulation panel

›INR and PT for consumption

›Rising INR as DIC marker

›Target normalization with plasma guided therapy

›aPTT for consumption

›Prolongation as DIC marker

›Fibrinogen

›Low fibrinogen as early severe abruption marker

›Replacement targets in active bleeding per obstetric massive hemorrhage protocols

›D dimer context

›Pregnancy baseline elevation limitation

›Trend and extreme elevation supportive of DIC

›Chemistry for organ injury

›Creatinine and electrolytes

›Acute kidney injury in shock

›Potassium abnormalities during massive transfusion

›AST and ALT if hypertensive disease concern

›HELLP overlap evaluation

Fetomaternal hemorrhage and Rh management

›Rh and fetomaternal hemorrhage evaluation

›Maternal ABO and Rh status

›Rh negative as Rh immune globulin trigger

›Kleihauer Betke or flow cytometry

›Fetomaternal hemorrhage quantification for Rh immune globulin dosing

06Diagnostic Tests/dt40

Scoring Systems

›Risk stratification and severity frameworks

›Shock index

›Heart rate divided by systolic blood pressure for early shock detection

›Rising value as escalation trigger

›ISTH DIC score adaptation

›Platelets, PT prolongation, fibrin related markers, fibrinogen

›Higher score supportive of overt DIC in bleeding patient

MRI

›Limited acute role

›Stable patient evaluation only

›Placental pathology characterization when diagnosis uncertain

›Not a time critical test in hemorrhage

›Practical constraints

›Availability and time delays

›Monitoring limitations in unstable patient

›Generally avoided for primary diagnosis

›Radiation considerations

›Use only when alternative diagnosis suspected and benefits outweigh risk

›Trauma evaluation pathways when indicated

›Alternative diagnosis support

›Intraabdominal injury after trauma

›Non obstetric abdominal catastrophe in pregnancy

Ultrasound (or US)

›Bedside imaging use

›Placental evaluation

›Retroplacental hematoma detection

›Placental thickening

›Subchorionic collection

›Test limitations

›Normal ultrasound does not exclude abruption

›Sensitivity limited especially in acute or concealed abruption

›Fetal assessment

›Fetal cardiac activity confirmation

›Amniotic fluid assessment

›Fetal presentation for delivery planning

Fetal monitoring

›Cardiotocography

›Continuous monitoring when viable gestation and resources

›Recurrent late decelerations as uteroplacental insufficiency marker

›Bradycardia as severe compromise marker

›Contraction monitoring

›Tachysystole association with abruption

›Hypertonus association with abruption

07Disposition/dispo20

Level of care

›Admission pathways

›Labor and delivery admission

›Suspected or confirmed abruption

›Any nontrivial bleeding with pain or uterine hypertonus

›ICU or high acuity monitoring

›Hemodynamic instability

›Ongoing transfusion requirement

›DIC or evolving coagulopathy

›Operative readiness

›Immediate access to cesarean delivery capability when indicated

›Anesthesia presence for unstable patient

Transfer and discharge

›Transfer criteria

›No obstetric operative capability locally

›Transfer to tertiary obstetric center

›Ongoing resuscitation during transfer

›Extreme prematurity with neonatal care needs

›Discharge criteria

›Generally uncommon for suspected abruption

›Minimal bleeding without pain and reassuring fetal assessment as obstetric decision only

›Clear return precautions and rapid follow up plan

08Treatment/t63

Resuscitation and hemorrhage control

›Immediate stabilization bundle

›Positioning

›Left uterine displacement

›Supine avoidance if symptomatic hypotension

›Fluids and products

›Balanced crystalloid as bridge only

›Early blood products for ongoing hemorrhage

›Massive transfusion protocol

›If ongoing hemorrhage with shock, activate immediately

›Targeted hemostatic resuscitation with lab guided adjustments

›Temperature and calcium

›Active warming

›IV calcium replacement during high volume transfusion

Blood products and hemostasis

›Packed red blood cells

›Transfusion triggers individualized to shock and ongoing bleeding

›Goal perfusion and oxygen delivery rather than single hemoglobin number

›Plasma and platelets

›If coagulopathy with bleeding, plasma support

›If thrombocytopenia with bleeding or operative need, platelets support

›Fibrinogen replacement

›Cryoprecipitate or fibrinogen concentrate based on local protocol

›If fibrinogen low with bleeding, replace early

›Repeat fibrinogen monitoring after replacement

›Tranexamic acid

›If massive obstetric hemorrhage, consider per institutional obstetric hemorrhage protocol

›Greatest evidence base in postpartum hemorrhage

›Use in antepartum hemorrhage as specialist guided decision

Obstetric management and delivery planning

›Delivery strategy based on maternal and fetal status

›If maternal instability, expedited delivery decision with obstetrics

›Cesarean delivery if viable fetus and maternal condition allows

›Vaginal delivery pathway if fetal demise and maternal stabilization achievable

›If fetal distress with viable fetus, expedited delivery

›If stable and mild suspected abruption, expectant management in hospital with continuous monitoring

›Avoidance of tocolysis in significant abruption

›Ongoing bleeding as contraindication to tocolysis

›Specialist decision only in selected mild cases

Medications and adjuncts

›Analgesia and antiemetics

›Opioid analgesia titrated to effect with maternal monitoring

›Antiemetic therapy if vomiting contributes to distress

›Corticosteroids for fetal lung maturity

›If preterm viable gestation and expectant management planned, antenatal corticosteroids per obstetrics

›Magnesium sulfate

›If imminent preterm delivery for neuroprotection per obstetrics

›Hypertension management

›If severe range blood pressure, antihypertensive therapy per obstetrics protocol

›IV labetalol protocol

›Initiate 20 mg IV

›If inadequate response, 40 mg IV after 10 minutes

›If inadequate response, 80 mg IV every 10 minutes

›Maximum cumulative 220 mg

›IV hydralazine protocol

›Initiate 5 to 10 mg IV

›Repeat 5 to 10 mg IV every 20 to 40 minutes

›Oral nifedipine immediate release protocol

›Initiate 10 mg orally

›Repeat 20 mg orally after 20 minutes if needed

›Antibiotics

›Not routine for abruption alone

›If chorioamnionitis suspected, broad spectrum antibiotics per obstetrics protocol

Rh immune globulin

›Rh negative patient pathway

›Rh immune globulin administration

›Dose per gestational age and fetomaternal hemorrhage testing

›Additional dosing guided by Kleihauer Betke or flow cytometry

09Special Populations/sp26

Pregnancy

›Pregnancy specific physiology and safety

›Increased plasma volume with delayed hypotension

›Tachycardia as early shock sign

›Concealed hemorrhage risk

›Aortocaval compression effects

›Left uterine displacement impact on perfusion

›Medication safety

›Avoid teratogenic agents

›Prefer obstetric approved hemorrhage protocols

›Coding and terminology

›Abruptio placentae ICD-10 O45.0 to O45.9

›SNOMED CT concept abruptio placentae

Geriatric

›Older pregnant patient considerations

›Higher baseline cardiovascular risk

›Lower tolerance for hypovolemia

›Earlier ICU threshold

›Medication sensitivity

›Lower opioid dosing thresholds

›Careful antihypertensive titration

Pediatrics

›Adolescent pregnancy considerations

›Confidentiality and safeguarding needs

›Screening for interpersonal violence

›Social work involvement when appropriate

›Lower baseline blood volume

›Faster decompensation risk

›Early blood product activation threshold

10Background/b33

Epidemiology

›Disease frequency and outcomes

›Placental abruption as a cause of antepartum hemorrhage

›Most common in third trimester

›Can occur at any gestational age

›Maternal outcomes

›Hemorrhagic shock risk

›DIC risk with severe abruption

›Fetal outcomes

›Preterm birth risk

›Fetal growth restriction association

›Stillbirth risk in severe cases

Pathophysiology

›Mechanism

›Premature separation of placenta from uterine wall

›Retroplacental hematoma formation

›Disruption of uteroplacental exchange

›Bleeding patterns

›Revealed bleeding with vaginal bleeding

›Concealed bleeding with intramyometrial tracking

›Coagulopathy pathway

›Tissue factor release and consumptive coagulopathy

›Hypofibrinogenemia as early marker in severe cases

Therapeutic Considerations

›Management principles

›Maternal stabilization reduces fetal risk

›Oxygen delivery and uterine perfusion dependence

›Delivery as definitive treatment for severe cases

›Maternal instability or fetal distress as common triggers

›Hemostatic resuscitation

›Early balanced blood product support

›Fibrinogen focused replacement in obstetric hemorrhage

›Evidence framing

›Many recommendations based on expert consensus and institutional obstetric hemorrhage pathways

›Class I recommendation for immediate obstetric consultation in suspected abruption with instability

›ACEP Level C recommendation for early massive transfusion activation in life threatening hemorrhage

11Patient Discharge Instructions/pdi17

copy discharge instructions

›Discharge counseling bundle

›Return to emergency care immediately for any of the following

›Heavy vaginal bleeding

›New or worsening abdominal pain

›Regular painful contractions

›Decreased fetal movements

›Dizziness, fainting, chest pain, shortness of breath

›Severe headache, vision changes, right upper quadrant pain

›Activity guidance

›Pelvic rest until obstetric follow up

›Avoid strenuous activity until cleared

›Follow up plan

›Same day obstetric assessment if any recurrence of symptoms

›Scheduled obstetric follow up within 24 to 48 hours if discharged by obstetrics

›Medication guidance

›Avoid NSAIDs unless explicitly advised by obstetrics

›Use prescribed analgesics only as directed

12References/r9

Clinical guidelines and key sources

›Core guidance sources

›ACOG practice bulletins and committee opinions on antepartum hemorrhage and placental abruption

›RCOG guidelines on antepartum hemorrhage

›Society for Maternal Fetal Medicine consult series on late pregnancy bleeding and placental complications

›Obstetric massive transfusion and hemorrhage protocols with fibrinogen focused resuscitation

›Evidence based summaries

›Major obstetric texts and review articles on diagnosis and ultrasound limitations

›DIC scoring framework publications including ISTH DIC score

›Trauma in pregnancy guidelines addressing placental abruption risk after blunt trauma

Learn More: Placental abruption→

Comprehensive Clinical Review

Structured, evidence-informed, long-form analysis for deeper understanding.

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed June 16, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.